Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
sipuleucel-t (Provenge) (2010 NDA)
sipuleucel-t (Provenge) (21 trials)
abiraterone (zytiga) (2 trials)
apalutamide (erleada) (1 trial)
dn24-02 (1 trial)
enzalutamide (xtandi) (2 trials)
leuprolide (lupron) (1 trial)
testosterone (delatestryl) (1 trial)
atezolizumab (Tecentriq) (1 trial)
d-3263 (1 trial)
Adenocarcinoma (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 3)
Trials (23 total)
Trial APIs (9 total)